eLife

aka eLife

A non-profit open-access life-science journal backed by HHMI, Wellcome and the Max Planck Society, known for its reviewed-preprint publishing model.

Fully open access. Since 2023 eLife publishes 'Reviewed Preprints' with public peer reviews and an editorial assessment instead of accept/reject decisions, a model that has been both praised and contested. Publishes cancer biology, evolution and computational studies, including reproducibility work on high-profile cancer papers.

Publisher

eLife Sciences Publications

Scope

basic cancer biology

Website

elifesciences.org

Access model

open access

Founded

2012

ISSN

2050-084X

Key papers published here

1top

meta analysis2021

Reproducibility Project: Cancer Biology found that landmark preclinical results mostly shrank or vanished on replication

Many exciting laboratory findings that motivate drug programmes are weaker or less reliable than published, which helps explain the high failure rate of drugs entering clinical trials. It argues for pre-registration, detailed methods, data sharing and independent replication before major translational investment.

Connected

0top

Nothing links here yet.